Mr. El-Hage is an expert in corporate governance, corporate finance, and valuation, with more than 20 years of professional experience in executive management positions, focusing in the areas of private equity, equity financing, restructuring, and venture capital. He has provided consulting in several litigation matters involving governance and valuation issues and has provided expert testimony at deposition. He has also served on the boards of numerous private and public companies, ranging from start-ups to those with several billion dollars in revenues. He is currently the independent chairman of the MassMutual Premier Funds, a $10 billion+ mutual fund complex.

In addition to his experience raising capital, Mr. El-Hage has hands-on experience as the CEO and CFO of operating companies. In those capacities he oversaw corporate expansion, raised capital, and restructured debt. As a professional with two public equity firms, he evaluated investment opportunities, led a successful public offering, and undertook extensive due diligence and financial modeling, as well as completing the sale of two portfolio companies.

In 2003, Mr. El-Hage became senior associate dean for external relations at the Harvard Business School, where he was also, at various times, a professor of management practice and the Thomas Henry Carroll/Ford Foundation Adjunct Professor of Business Administration. He introduced and taught a new elective course on management and governance of active investing, in addition to courses in leadership and corporate accountability, and corporate finance. He was voted Capstone Professor six times, a rare honor, and was also awarded the prestigious Student Association Teaching Award in 2006.

Dr. Yang is an expert in health economics and outcomes research (HEOR), with extensive experience in developing comprehensive HEOR strategies to support products throughout their entire life cycles. As part of her diverse portfolio of HEOR case work, she has developed robust launch strategies; generated real-world data (RWD); and created clinical, economic, and humanistic evidence to support product value propositions. Notably, Dr. Yang has led case teams in preparing submissions to health technology assessment (HTA) agencies across the world, including those in the UK, France, Germany, Norway, Australia, Canada, and Japan. She has also conducted numerous studies across various therapeutic areas – such as autoimmune diseases, infectious diseases, diabetes, blood disorders, oncology, women’s health, and rare diseases – and worked across diverse treatment paradigms, including one-time interventions involving cell and gene therapies, as well as recurrent treatment regimens. Dr. Yang’s work has been widely published in peer-reviewed journals and featured at health care conferences.

Read Hongbo's profle

Professor Madnick specializes in database technology, connectivity among disparate distributed information systems, software project management, and the strategic use of information technology (IT). He is an experienced expert witness and has provided testimony in numerous litigation matters, including multiple cases involving Microsoft. Professor Madnick has also consulted to several major corporations, including IBM, AT&T, and Citicorp. He is co-head of the Total Data Quality Management (TDQM) Program and founding director of MIT’s Interdisciplinary Consortium for Improving Critical Infrastructure Cybersecurity, also known as (IC)³. Professor Madnick was the principal investigator of a large-scale research effort funded by the US government’s Defense Advanced Research Projects Agency (DARPA) on context interchange, which involved the development of technology that helps organizations work more cooperatively and collaboratively. His industry work includes contributions to projects such as IBM’s VM/370 operating system and Lockheed Martin’s DIALOG information retrieval system. He has also founded or co-founded several high-tech firms, including Intercomp, acquired by Logicon; Mitrol, acquired by General Electric; the Cambridge Institute for Information Systems, subsequently renamed Cambridge Technology Group; and iAggregate, acquired by ArsDigita, which was subsequently acquired by Red Hat. Professor Madnick has authored or coauthored over 400 books, articles, and technical reports.

Dr. Sutcliffe's expertise is in the areas of strategic management and organization theory. Her research has been aimed at understanding how organizations and their members cope with uncertainty and unexpected events, and how complex organizations can be designed to be more reliable and resilient. Dr. Sutcliffe is a coauthor of Managing the Unexpected: Resilient Performance in an Age of Uncertainty (2007) and Medical Error: What Do We Know? What Do We Do? (2002). She has published her research on high-reliability organizations, organizational resilience, and safety culture in numerous management and health care journals, and she has presented her findings nationally and internationally. Dr. Sutcliffe has also consulted with private multinational companies in a variety of industries, and with nongovernmental organizations and government agencies. She was recently appointed by The National Academies to a research panel on workforce resilience that will study and provide recommendations to the US Department of Homeland Security. She has received multiple grants, including a 2010 award from the Robert Wood Johnson Foundation to conduct a study of the medicalization of patient safety. Dr. Sutcliffe has served on the editorial boards of several academic journals, including Organization Science, Academy of Management Journal, Organization Studies, and the International Public Management Journal.

Dr. White specializes in health care, transfer pricing and valuation, and general commercial litigation. He combines his expertise in applied microeconomics, statistics, and econometrics with nearly 25 years of experience with client engagements. A diverse range of clients have retained Dr. White to assist in all stages of the litigation cycle – including advising on discovery issues, expert report preparation, and preparation for deposition and trial. He has worked on general commercial litigation matters such as allegations of false advertising and breach of contract, investigations into alleged off-label promotion of prescription drugs, and the economic impact of generic drug entry/substitution. Additionally, he has also analyzed economic issues relevant to class certification and quantification of damages.

Dr. White has managed numerous commercial litigation matters, supporting academic and industry specialists with expertise in industrial organization, statistics, health economics, and marketing. His tax and transfer pricing work has evaluated the arm’s length nature of pricing in intercompany transactions, and the estimation of useful economic lives for various tangible and intangible assets. In addition to his litigation work, Dr. White’s health economics engagements have included the development of empirical models for evaluating factors to help identify patients at risk of prescription opioid abuse, as well as the estimation of societal economic costs of prescription opioid abuse.

An active researcher, Dr. White’s publications have focused on specific health economics issues, such as the economics of prescription opioid abuse and the evaluation of the impact of biosimilar approval on the litigation landscape. He has presented and participated in a number of industry conferences. Dr. White is an adjunct faculty member in the Department of Economics at Northeastern University, where he teaches courses on applied microeconomics and applied econometrics.

Professor Sussman focuses his research in the areas of real estate investment and finance, financial statement analysis and valuation, and corporate financial reporting. He has consulted to large and small firms nationally and globally, and is a frequent lecturer on a variety of financial, accounting, and corporate reporting topics. Professor Sussman has served as an expert witness and consultant in commercial litigation involving matters of real estate due diligence and related practices, corporate financial reporting and disclosure, audit effectiveness, valuation, and overall damage analyses. He is a founding partner of Clear Capital, where he oversees the firm’s capital, equity, and debt departments and strategic planning functions, and provides leadership to the firm in the areas of private equity, joint ventures, and fund formations. Professor Sussman is also president of Amber Capital; manager of Fountain Management; and managing partner of the Pacific Value Opportunities Fund and Clear Opportunity Fund, which have acquired, rehabilitated, developed, and managed over 2 million square feet of residential and commercial real estate. He also serves as the audit committee chairman of the board of trustees of Causeway Capital’s group of funds, which collectively have more than $15 billion in assets. Professor Sussman is a licensed certified public accountant in the State of California. 

Professor Reibstein’s research focuses on competitive marketing strategies, metrics, and product line decisions, among other topics. He has provided marketing management education and consulting research to companies in the consumer goods, pharmaceutical, and oil and gas industries, among others. His consulting activities have included numerous applications of conjoint analysis and other survey techniques in engagements spanning a wide range of products. Professor Reibstein has submitted expert reports and provided testimony on marketing and marketing research in several litigation matters, including analyses of smartphone features in a patent dispute, health claims in a false advertising dispute, and pharmaceutical detailing in a co-marketing dispute.

His recent work includes assessing strategies to address competitors’ reactions to marketing actions and developing metrics that link marketing decisions to financial consequences, which was published in his book, Marketing Metrics: The Definitive Guide to Measuring Marketing Performance. Professor Reibstein is also the author or coauthor of numerous books and chapters in books on subjects including competitive marketing strategy, global branding, and marketing performance measurement. Professor Reibstein has also written several papers on conjoint analysis and its validity and reliability. His research has been published in leading academic journals, including Marketing Science, the Journal of Marketing Research, and the International Journal of Research in Marketing.  

Professor Reibstein has been honored with more than 30 teaching and publishing awards, including the John S. Day Distinguished Alumni Academic Service Award from Purdue University’s Krannert School of Management. He has served as the chairman of the American Marketing Association board of directors and as the executive director of the Marketing Science Institute.

Mr. Hutchings’ economics expertise spans a wide array of topics, including tax and transfer pricing, securities and finance, valuation and damages, and antitrust. Deeply experienced in litigation, international arbitration, and investigations, he has led case teams, conducted economic and financial analyses, estimated damages and liability, and performed valuation analyses in complex matters across many jurisdictions, including the US, Canada, the UK, the EU, Latin America, and Australia.

In tax controversy and transfer pricing matters, he has assisted expert witnesses and attorneys for both taxpayers and taxing authorities in jurisdictions around the world. Mr. Hutchings has analyzed intercompany financings for both debt/equity characterization and debt pricing questions, valued closely held corporations, studied issues of cost allocations between related parties, and assessed arm’s-length pricing in a variety of contexts. For example, he has worked with financial institutions on allocating losses amongst subsidiaries, studied the sources of value for consumer packaged goods, priced related party transactions for pharmaceutical products, and worked with medical device manufacturers on transfer pricing between related parties. Mr. Hutchings has provided expert reports on tax dispute and transfer pricing issues for both planning and litigation. He has also applied transfer pricing principles in non-tax disputes such as assessing fairness in corporate transactions between related parties.

In antitrust and competition matters, Mr. Hutchings has analyzed anticompetitive effects, evaluated potential remedies, examined the economics of platform markets, and assisted in the preparation of analysis and testimony before courts and government regulators, such as the US Federal Trade Commission (FTC).

In addition, he has quantified harms and foregone benefits, and valued natural resources and treaty entitlements, in several disputes between Canadian First Nations and the Crown, both testifying at trial and consulting to reach pre-dispute resolutions. He has also quantified damages arising from tortious interference, breach of contract, and other contractual and extra-contractual remedies, and provided valuation analyses in numerous commercial disputes.

Ms. Wood is an expert in institutional investing, global corporate governance, equity and bond portfolio management, financial analysis, and securities analysis, with over 35 years of experience in the asset management industry. She also has expertise in investment management and asset allocation of pension funds, mutual funds, insurance companies, endowments, and foundations. She has served as an expert witness in litigation involving asset allocation, investment policy, investment manager due diligence, public pension plans, corporate governance, securities analysis, and portfolio management.

Ms. Wood led the $150 billion equity, hedge fund, and activist portfolios for the California Public Employees’ Retirement System (CalPERS), the largest public pension plan in the US. She also managed the CalPERS corporate governance program and Focus List engagements, including its environmental, social, and governance (ESG) strategies. Ms. Wood’s other ESG activities include serving as board chair of the Global Reporting Initiative, tasked with setting global sustainability disclosure standards for over 5,000 companies worldwide. She is a former CEO of Capital Z Asset Management, one of the largest independent sponsors of hedge funds, where she was responsible for minority equity ownership in 11 hedge funds across $7 billion in equity, fixed income, and commodity strategies.

Ms. Wood serves on numerous boards of directors, having chaired the audit, corporate governance, and investment committees of the boards of several financial institutions. Previously, she was a member of the Financial Accounting Standards Board (FASB) Investor Advisory Group, the Public Company Accounting Oversight Board (PCAOB) Standing Advisory Group, and the International Auditing and Assurance Standards Board (IAASB) Consultative Advisory Group. She is a frequent speaker on topics that include sustainability reporting, corporate governance, ESG disclosure, best practices of boards of directors, global alpha generation, and hedge funds. Ms. Wood was a 2018 Harvard University Advanced Leadership Fellow.

Professor Fader is a marketing expert who analyzes behavioral data to understand and forecast customer shopping and purchasing activities, determine customer lifetime value, and assess customer relationship management activities. His research highlights the consistency of customer behavior patterns across industries, as well as methods for leveraging this information to create more effective marketing strategies. He has provided expert testimony in litigation, and he has consulted to firms in a range of industries, including consumer packaged goods, interactive media, financial services, retailing, and pharmaceuticals. Professor Fader has published numerous journal articles and book chapters on a variety of marketing and applied statistics topics. He is the author of Customer Centricity: Focus on the Right Customers for Strategic Advantage (2020) as well as coauthor of The Customer Centricity Playbook: Implement a Winning Strategy Driven by Customer Lifetime Value (2018). He has been on the editorial boards of several journals, including Marketing Science, the Journal of Marketing Research, and the International Journal of Research in Marketing. In addition to his academic career, Professor Fader has brought his customer-oriented expertise to the marketplace in his capacity as co-founder of the predictive analytics firm Zodiac and the customer-based corporate valuation firm Theta.

A specialist in finance and securities, Dr. Wong has managed teams supporting academic and industry affiliates in litigation matters involving securities fraud, damages, bankruptcy, suitability analysis, portfolio management, mortgage lending practices, accounting analysis, market manipulation, and financial statement analysis. He has extensive experience analyzing fixed-income instruments, structured finance instruments, and credit derivatives. Dr. Wong has worked on and provided testimony in government regulatory investigations. His recent engagements include work in legal disputes related to structured finance instruments, including residential mortgage-backed securities (RMBS) and collateralized debt obligations (CDOs); securities lending; mutual funds and other commingled investment pools; corporate governance; and investment suitability claims. He has also worked on valuation, class certification, and intellectual property matters.

Dr. Wong joined Analysis Group from Chicago Partners in 2006, and has played an instrumental role in the development and growth of the firm’s Chicago practice. He is a member of the American Finance Association and has published research on bankruptcy and the financing of new firms.

Read Andy's profile

Ms. Arcelus specializes in analyses of complex problems in business litigation from technology, economic, and financial perspectives. Her litigation experience includes all aspects of diverse litigation matters. Ms. Arcelus frequently works with an extensive network of experts from leading universities, as well as distinguished industry experts, to apply innovative and established techniques to her engagements.

In more than three decades at Analysis Group, she has managed high-profile litigation projects across a variety of areas, including antitrust and competition, intellectual property, data protection and privacy, technology, cybersecurity, biometric data, algorithm use, regulatory compliance, impact of misleading information technology, and contract disputes. Her work often involves leading companies in technology-intensive industries such as digital platforms, biotech, engineer systems, computer hardware, and software. Ms. Arcelus has worked on cases in the US, Canada, Latin America, and Europe.

Ms. Arcelus has also worked on securities class action cases involving institutional responsibility and investor knowledge; energy litigation projects involving contract and price disputes; labor litigation involving no-poach agreements; and health care consulting projects involving the statistical modeling of clinical outcomes, pharmacoeconomic analyses, and strategic financial analyses.

Professor Tadelis is an expert on e-commerce and the economics of the internet, industrial organization, and microeconomics, including game theory and auction theory. His work on e-commerce investigates online auctions and online bargaining, digital advertising, seller reputation and the determinants of trust, price salience, and algorithmic pricing. Professor Tadelis has also researched contract theory and design, with applications to outsourcing, privatization, strategic pricing, public and private sector procurement and award mechanisms, and strategic sourcing and pricing. He has been engaged by regulatory authorities and tech companies in a variety of investigations and litigation matters in both the US and Canada on topics such as consumer protection, pricing, and online advertising and has testified at deposition.

Professor Tadelis has a decade of experience working with online marketplaces and retailers. He served as a senior director and distinguished economist at eBay Research Labs, where he hired and led a team of economists focused on the economics of e-commerce, with particular attention to creating better matches of buyers and sellers; reducing market frictions by increasing trust and safety in eBay’s marketplace; understanding the underlying value of different advertising and marketing strategies; and exploring the market benefits of different pricing structures. He also served as vice president of economics and market design at Amazon, where he guided and supported economic analyses for business decisions across the company.

Professor Tadelis participated in the Federal Trade Commission’s 2018 hearings on “Competition and Consumer Protection in the 21st Century.” He testified on two panels: “Multi-Sided Platforms in Action” and “Nascent Competition: Is the Current Analytical Framework Sufficient?”

Professor Tadelis is the author of books on game theory and microeconomic theory, as well as a handbook chapter on two-sided e-commerce marketplaces and the future of retailing. He has published articles in and served on the editorial boards of leading economics, marketing, and management journals. He is a research associate at the National Bureau of Economic Research and a research fellow at the Centre for Economic Policy Research.

Professor Riddiough is best known for his work on real options, mortgage pricing and strategy, REITs, and land use regulation. He has served as an expert in numerous real estate-related matters, in which he has testified on appraisal and the value of distressed mortgages. Professor Riddiough has consulted to numerous organizations, including the US Department of Housing and Urban Development, GMAC, Wells Fargo, Coldwell Banker Commercial, The Equitable Life Assurance Society, and the State of Wisconsin Investment Board. He has published more than 40 scholarly articles. He has served on the boards of directors of several organizations, including ArCap REIT, EquiBase Capital Partners, and the American Real Estate and Urban Economics Association. Professor Riddiough is the recipient of best dissertation and best paper awards in real estate economics, and is a fellow at the Real Estate Research Institute and a past fellow at the Homer Hoyt Institute. He teaches courses in real estate finance, real estate capital markets, and microeconomics.

Dr. Chakraborty is an economist with an extensive background in economics, finance, accounting, and valuation. She has been retained both as an expert witness and as a consultant in a number of matters involving equity and fixed income securities, valuation, solvency, fraudulent conveyance, and economic damages. Dr. Chakraborty has conducted analyses in matters involving bankruptcy, mergers and acquisitions (M&A), tax and transfer pricing, international arbitrations, fraud, and theft of trade secrets and misappropriation. Her work has involved the development of financial and economic models, the evaluation of large datasets, and the application of statistical methods to a variety of complex problems. She has worked on matters involving companies in many industries, including financial services, energy, retail, and pharmaceuticals.

Mr. FitzPatrick is a wealth management and fiduciary expert with extensive experience serving high-net-worth individuals, families, and related charitable entities. In his role at Northway Wealth Advisors, he provides guidance to trustees of personal trusts and executors of estates, and mediation and expert witness services in support of fiduciary-related dispute resolution. Mr. FitzPatrick has been recognized as a court-qualified expert in wealth management matters and has served as a testifying expert in multiple trust and estate cases. He is a columnist and author of articles published in The International Family Offices Journal and Trusts & Estates magazine. Prior to founding Northway, he held senior executive roles with Dominion Fiduciary Services, Webster Bank, BNY Mellon, J.P. Morgan, Citigroup, and Goldman Sachs, among others. Notably, he led J.P. Morgan Private Bank’s global trust and estate administration business, which managed accounts valued at more than $21 billion. Subsequently, Mr. FitzPatrick served as managing director and head of trust for Goldman Sachs, where he chartered and built both The Goldman Sachs Trust Company, N.A., and The Goldman Sachs Trust Company of Delaware, and grew combined assets under fiduciary supervision from zero to $2 billion in under four years. He then ran Citigroup’s global personal trust business, managing more than $50 billion in fiduciary accounts. He is a member of several nonprofit boards and committees and has held numerous leadership positions with industry associations and on professional and corporate boards. Mr. FitzPatrick is a registered Trust and Estate Practitioner (TEP) and a Master Certified Independent Trustee.

Mr. Jarosz is an economist and director of Analysis Group’s Washington, DC office. He specializes in matters involving intellectual property (IP), commercial damages, licensing, and antitrust. His IP work focuses on evaluating lost profits, reasonable royalties, price erosion, commercial success, licensing terms, best efforts, irreparable harm, and FRAND commitments. Mr. Jarosz has significant expertise testifying in patent, trademark, copyright, and trade secret tort and contract matters. He is also experienced in both US and international arbitration, often serving as an expert witness in matters involving IP rights.

A frequent author and lecturer on the economics of IP protection, Mr. Jarosz has participated in and given presentations at various meetings of the Sedona Conference, Intellectual Property Owners Association, Licensing Executives Society, and the Association of University Technology Managers. He has published a variety of papers in professional and practitioner journals, and he has taught classes at Georgetown University Law Center, George Washington University Law School, the University of Pennsylvania Law School and Department of Economics, Columbia Business School, and the US Patent and Trademark Office. Mr. Jarosz has been recognized for many years as among the top economic experts for IP matters by Intellectual Asset Management (IAM) in the IAM Patent 1000, which identifies leading patent professionals around the globe.

Professor Wright is an expert in accounting, public policy, and resource allocation related to petroleum. She focuses her work on international petroleum contracts, upstream oil and gas accounting, and financial reporting, as well as on the disclosure and valuation of oil and gas reserves. Her research has examined accounting issues for environmental costs and asset retirement obligations, petroleum economics and decision analysis, joint interest accounting, and the evaluation of oil and gas financial statements. Over the past two decades, Professor Wright’s expertise in petroleum economics and valuation has been called on in support of numerous litigation matters. In these engagements, she has served as a witness, filed expert reports, and provided testimony at deposition and trial.  Professor Wright has authored dozens of research publications and is the coauthor of two textbooks, Fundamentals of Oil & Gas Accounting and International Petroleum Accounting. She has served on the editorial review boards of several publications, including Petroleum Accounting and Financial Management Journal and Oil, Gas & Energy Quarterly, and was a member of the International Accounting Standards Board’s extractive industries advisory committee. Professor Wright is a certified public accountant in Oklahoma.

Professor Melvin has lengthy academic and business experience in international finance – including foreign exchange market microstructure – and multi-asset investment strategies. His current research focuses on currency carry trades, currency transaction costs, and exchange rate models. Professor Melvin has published widely on topics that include exchange rates, currency investing, and international equity markets. Previous faculty appointments have included Arizona State University’s W.P. Carey School of Business; the Haas School of Business at the University of California, Berkeley; the University of California, Los Angeles; and Northwestern University.

In addition to his academic achievements, Professor Melvin has deep in-house experience in the finance industry. Before joining the Rady School, he was managing director and senior research advisor in multi-asset strategies at BlackRock. He also served as the head of currency and fixed-income research in the Global Market Strategies Group at BlackRock and Barclays Global Investors. Professor Melvin is former coeditor of the Journal of International Money and Finance, and he has been a visiting scholar at the Federal Reserve Board, the International Monetary Fund, and the Bank for International Settlements.

Dr. Wu is a health economist with expertise in health economics and outcomes research (HEOR), market access, and scientific evidence strategy. He has conducted research in more than 30 countries on behalf of pharmaceutical and medical device companies, payers, providers, and government agencies. Dr. Wu has contributed to over 200 publications across dozens of therapeutic areas, including regenerative therapies (gene and stem cell), rare and ultra-rare diseases, biologics, and immuno-oncology.

Dr. Wu spends a significant portion of his practice developing new scientific methods to address challenges in health care research. He has developed client-focused solutions based on the use of artificial intelligence (AI), medical big data, real-world evidence, and innovative comparative-effectiveness research methodologies.

Professor Thurman is an expert in agricultural markets and regulation. He has consulted on a wide variety of topics related to agriculture, including competition in agricultural markets, international trade in agricultural commodities, the behavior of agricultural futures markets, the proper use of econometric methods, damages assessments, the role of agricultural cooperatives, and the estimation of cost pass-through to indirect purchasers. As an expert witness, Professor Thurman has testified at deposition and in federal and state court proceedings. He has published widely on agricultural and natural resource subjects, including grower compensation in the poultry industry, food safety regulation in the egg industry, the effects of supply control programs for peanuts and tobacco, honeybee pollination markets and colony collapse disorder, the performance of lumber futures markets, and the costs of the Clean Water and Clean Air Acts. At North Carolina State University, Professor Thurman taught graduate and undergraduate courses in econometrics, microeconomics, and agricultural markets. He is the recipient of numerous research and teaching awards and fellowships, including the Agricultural & Applied Economics Association’s (AAEA’s) Publication of Enduring Quality and Outstanding Graduate Instructor Awards. Professor Thurman is a past editor of the American Journal of Agricultural Economics, an elected fellow of the AAEA, and a senior fellow of the Property and Environment Research Center in Bozeman, Montana.

Professor Schoar is an expert in corporate finance, entrepreneurship, and organizational economics. Her research examines returns and capital flows in the venture capital industry, the financing of small- and medium-sized enterprises and startup firms in emerging markets, and the impact of corporate governance practices on firm performance. Professor Schoar has served as an expert witness in cases involving commercial litigation and financial services. She is co-chair of the Corporate Finance Program at the National Bureau of Economic Research and co-founder and scientific director of ideas42, a research lab on behavioral social science. She has published numerous articles and papers and received several awards for her research, including the Ewing Marion Kauffman Prize Medal for Distinguished Research in Entrepreneurship, and the Brattle Group Prize in Corporate Finance for her paper “The Effects of Corporate Diversification on Productivity.” She is the executive editor of The Journal of Finance and previously served as an associate editor of the American Economic Journal: Applied Economics, the Journal of Economic Perspectives, and the Journal of Financial Intermediation. Professor Schoar’s work has been featured in The Economist, the Financial Times, The New York Times, and The Wall Street Journal.

Mr. Yeater specializes in applying financial and economic analyses to complex business litigation and regulatory matters involving antitrust concerns, intellectual property claims, and other commercial disputes. Mr. Yeater serves as an expert witness and consults to clients in non-testifying roles. In more than 20 years as an economic consultant, he has led large, high-profile engagements supporting multiple experts in a variety of industries, including digital and traditional media, sports and entertainment, retail consumer goods, high-tech consumer products, pharmaceuticals, chemicals, agriculture, education, and financial services.

Mr. Yeater applies his expertise to analyze competition and substitution patterns, define relevant markets, and evaluate potential competitive effects and counterfactual outcomes in merger and competition investigations and antitrust litigation. He has served as a testifying economist concerning the analysis of merger efficiencies and procompetitive effects of conduct. Mr. Yeater has also evaluated competition, pricing, output and efficiencies, and procompetitive benefits in connection with merger and behavioral investigations in the US, Australia, Korea, the UK, and the EU. He has supported merging parties and the Federal Trade Commission (FTC) in a variety of merger investigations. In other litigation matters, Mr. Yeater has applied his expertise in financial and economic concepts to the analysis of damages, and has provided assistance throughout all phases of pretrial and trial practice.

Mr. Yeater serves as a vice chair to the American Bar Association (ABA) Antitrust Law Section’s Podcasting Committee, producing and hosting episodes of the committee’s Our Curious Amalgam podcast. Previously, he was a vice chair of the Food and Agriculture Committee. He publishes and presents regularly on topics relevant to his expertise, including the economic analysis of competition, the calculation of damages in antitrust and other cases, and class certification.

Mr. Jetley specializes in mergers and acquisitions (M&A), valuation of derivative instruments, securities valuation, corporate finance, and risk management. He has worked on several transaction-related matters that involved the analysis of target valuations, sales processes, disclosures made by bidders and targets, and other deal terms. His securities valuation experience includes analyzing the impact of selected disclosures on the stock price of large corporations across a variety of industries, including technology, electric utilities, office equipment, biotechnology, real estate investment trusts (REITs), and health care providers. Mr. Jetley has also worked on several matters involving the valuation of equity, fixed-income, foreign exchange, and mortgage-backed derivative securities. He frequently publishes and presents on topics involving M&A, securities, financial analysis, and commercial damages.

Professor Meyer specializes in software engineering and the construction of complex reliable systems. His research interests run from the technical (such as software verification, programming languages, and concurrent programming) to the managerial (including large project organizations, agile methods, quality assurance, and troubled-project rescue). Professor Meyer has served as an expert witness in technology-related cases before the US International Trade Commission (ITC), the European Commission (EC), and the International Chamber of Commerce. These include a patent litigation case between Nokia and Apple before the ITC, and a Microsoft antitrust case before the EC. He has consulted to companies in the US, Japan, and Europe. A pioneer of object technology – a now-dominant approach to software design and programming – Professor Meyer designed the Eiffel programming language and established the “design by contract” (DbC) programming concept. Professor Meyer has published over 300 articles and 12 books, many widely translated, on software issues and techniques. His awards include the IEEE Computer Society’s Harlan D. Mills Award and the Association for Computing Machinery (ACM) Software System Award; he is a member of Academia Europaea, and a fellow of the International Federation for Information Processing (IFIP) as well as the ACM. After co-founding Eiffel Software, he was a professor of software engineering and chairman of the Department of Computer Science at ETH Zürich. In addition to his current role at the Schaffhausen Institute of Technology in Switzerland, Professor Meyer holds associated positions with Politecnico di Milano, the University of Toulouse, and Russia’s Innopolis University. He speaks English, French, Russian, German, and Italian.

Dr. Chawla has more than 25 years of experience as an economist in the health care sector. Since joining Analysis Group in 2007, she has helped global biopharmaceutical, diagnostic, and medical device manufacturers - as well as development-stage companies - address product development and commercialization objectives, particularly as they relate to market access. Her work has spanned a wide range of therapeutic areas, including multiple indications in oncology. Her recent client work includes landscape assessments, economic modeling, and strategic plans to inform evidence generation in the context of product development and market access launch strategy; forecasts to help prioritize research and support licensing and venture funding discussions; payer research and advisory boards; and launch materials that communicate a product's clinical and economic value to support evidence-based reviews. Dr. Chawla recently led an engagement comprising a fully integrated market access strategy and related tactics to support the launch of a novel drug to treat an orphan disease.

Dr. Chawla's recent publications include an assessment of the impact of regulatory requirements for cardiovascular risk evaluation for diabetes therapies. She has served as a reviewer or referee for several journals, including Value in Health, Health Affairs, Health Services Research, Journal of the American Medical Association, and Journal of Business and Economic Statistics. Prior to joining Analysis Group, she was head of the health economics and outcomes research department at Genentech, Inc., where she also supported the oncology franchise.

Professor Toubia has marketing expertise in the areas of innovation and new product development, with a specific emphasis on market research, behavioral economics, preference measurement, and customer choice models. He focuses his research primarily on studying how firms can optimize their interactions with customers. For example, he has used polyhedral adaptive choice-based conjoint analysis to develop marketing strategy and assessed the comparative value of promotional efforts launched through online social communities versus traditional direct-mail campaigns. Professor Toubia has conducted numerous surveys for litigation – including conjoint studies – involving smartphones, set-top boxes, consumer packaged goods, medical equipment, and perceptions of employment status. He has also been deposed and testified at an arbitration matter.

Professor Toubia worked with Applied Marketing Science on the development of IDEALYST®, an online idea generation and group brainstorming tool that has been used by numerous corporations to enhance output and creativity through the use of incentives. His research has been honored with three John D.C. Little Best Paper Awards and published in a variety of marketing outlets. Among other journal affiliations, Professor Toubia is coeditor of Quantitative Marketing and Economics, associate editor of Management Science and Marketing Science, and a member of the editorial boards of International Journal of Research in Marketing and Journal of Marketing Research.

Professor Wruck's research and teaching are in the fields of financial and organizational economics, with special emphasis on corporate finance, restructuring, financial distress, governance, and management compensation. She has served as an academic director of the Financial Management Association and the Turnaround Management Association, consulted to major corporations, and has worked on a number of high-profile corporate litigation projects as a subject matter expert.  Professor Wruck has published numerous articles in leading academic journals, and her work and opinions have been highlighted in several business periodicals. In addition to refereeing for several industry journals, she serves as an advisory editor for the Social Sciences Research Network (SSRN) and the Organizations and Markets Electronic Journal. She is also a former associate editor of the Journal of Financial Economics, the Journal of Corporate Finance, The Journal of Financial Research, and European Financial Management. Professor Wruck’s honors include Ohio State's Mary Ann Williams Award, which recognizes a woman exhibiting extraordinary leadership, and Fisher's Bostick-Georges Pacesetter Service Award, which recognizes exceptional leadership and service to the College of Business. In addition, she has on multiple occasions been selected as outstanding professor by Ohio State's full-time and executive M.B.A. programs. Prior to her appointment at Ohio State, Professor Wruck served on the faculty of the Harvard Business School.

Professor Snyder is an industrial organization economist whose research focuses on antitrust policy and enforcement, contracting practices, financial institutions, and law and economics. He has consulted on and served as a testifying expert in numerous high-profile cases, opining on liability, damages, proposed mergers, price-fixing allegations, Hatch-Waxman claims involving pharmaceuticals, monopolization claims, and proposed class certifications of both direct and indirect purchasers. In addition, Professor Snyder has testified before combined US Federal Trade Commission (FTC) and US Department of Justice (DOJ) hearings on competition and intellectual property, and has presented separately before the DOJ’s Antitrust Division, where he worked as an economist earlier in his career, and the FTC. He has been a signatory to amicus briefs submitted to the Supreme Court on various price-fixing and Sherman Act issues.

Professor Snyder has written extensively on topics related to antitrust and policy issues, with his articles appearing in prestigious publications such as The Journal of Law and Economics, the Journal of Comparative Economics, The Antitrust Bulletin, and Contemporary Policy Issues. His work has also been featured in major media outlets, including the Financial Times, The Wall Street Journal, and The New York Times.

Professor Snyder also served as the dean of the Yale School of Management from 2011 to 2019, during which time he enhanced the school’s academic programs and financial standing, and established new master’s programs in the areas of management, entrepreneurship, and executive education. He also founded the Global Network for Advanced Management at Yale University, an international consortium of schools devoted to teaching tomorrow’s business leaders around the world. Prior to joining Yale, Professor Snyder was the dean of the business schools of The University of Chicago, the University of Virginia, and the University of Michigan.

Mr. Ji specializes in the application of economics and finance to litigation matters in the areas of mergers and acquisitions (M&A), valuation, financial instruments, and tax. He has significant experience supporting academic and industry experts, as well as providing consulting assistance to clients. Mr. Ji has examined all aspects of M&A, including bid premiums, public and private benefits of control, deal terms, sales mechanisms, negotiation processes, shareholder activism, merger arbitrage, advisor fees, material adverse event (MAE) and material adverse change (MAC) provisions, and consequences of breaching non-disclosure or standstill agreements. His valuation experience includes analyzing real estate, telecommunications, energy, public transportation, medical devices, and banking and brokerage companies and assets. In the bankruptcy area, he applies his valuation skills to solvency and fraudulent conveyance analyses. Mr. Ji has managed case teams in matters involving various types of financial instruments and markets, including foreign currencies, auction-rate securities, precious metals, and fixed-income derivatives. In securities litigation matters, he has assisted counsel and experts throughout all stages, including class certification, merit, mediation, and settlement negotiation, and has addressed issues such as price impact, loss causation, damages methodology, materiality, and falsity. He has also assessed the economic substance and structure of various complex tax shelter transactions. Mr. Ji’s research papers have been published in the Financial Analysts Journal and The Business Lawyer.

Professor Fox’s research focuses on retail pricing, promotion, and assortment management, as well as the quantitative modeling of consumer shopping behavior to address retail competition and marketing channel issues. He frequently estimates models using customer-level data to identify the drivers of shopping behavior and to make shopping and spending predictions, which can then be used by retail decision makers to improve store performance. Professor Fox has consulted to retailers and other companies on marketing management, strategy, and quantitative decision making. His clients have included ACME Markets, Genuardi’s Family Markets, Ben E. Keith, Andrews Distributing, Softspikes, Arcis Golf, and Reliant Rehabilitation. In Federal Trade Commission, et al. v. The Kroger Company, et al., Professor Fox analyzed the consequences for consumers of the parties’ divestiture plan, which involved the sale of hundreds of stores and distribution centers. He opined that many of the divested stores would not be able to succeed and, as a result, the divestiture would be insufficient to remedy the harm to consumers caused by the merger. Professor Fox’s research has addressed topics such as dynamic pricing, demand estimation using transaction data, competitive issues in retailing, consumer spending behavior across retail formats, and recapturing lost customers. His articles have been published in journals such as Marketing Science, the Journal of Marketing Research, the Journal of Marketing, Management Science, Operations Research, Quantitative Marketing and Economics, and the Journal of Retailing. He is frequently quoted in the media on retail marketing and consumer buying behavior, and he has spoken at numerous industry conferences and trade association meetings.

Professor Anderson conducts research on the design of cost accounting systems and on how firms use management control practices to mitigate risk and facilitate collaboration in inter-firm transactions. This research includes performance measurement, incentive contracting, supply chain contracting, and operations management. Professor Anderson uses empirical analysis of firm-level accounting and operational data to test economic theories about firm performance. She also has experience designing and administering surveys and analyzing survey data. Her published work has employed data from many industries including automotive, electronics manufacture, office furniture manufacture, commercial airlines, consumer retail, coal extraction, transportation, and warehousing and distribution. 

Professor Anderson co-authored the award-winning book Implementing Management Innovations and the textbook Fundamentals of Cost Accounting (now in its 5^th edition). Her research has been published in leading research journals including The Accounting Review, Management Science, and Contemporary Accounting Research. She has been recognized with the American Accounting Association's Notable Contribution Award (2006) and with the American Accounting Association's Management Accounting Section's Notable Contribution to the Literature Award (2003, 2006, 2012) and the Greatest Influence on Practice Award (2010). Professor Anderson's research has been funded by competitive grants from the AICPA, the Institute of Internal Auditors, the Institute of Management Accountants, the National Science Foundation, and the Australian Research Council.

Professor Anderson has previously held faculty positions at the University of Michigan and Rice University. She has also held visiting faculty appointments at Harvard Business School and the University of Melbourne. Earlier in her career, she worked as an engineer for General Motors Corporation. 

Mr. Trautman leads the media and entertainment practice of Bortz Media & Sports Group, with more than 30 years of experience and an analytical focus on all aspects of media – including video programming, industry, firm- and product-level performance and prospects, market forecasting and trends, and audience behavior. He has provided both consulting and expert witness services to a wide range of corporations, including Comcast, Discovery Communications, Disney/ESPN, Gannett, Major League Baseball, and TiVo. He has also submitted testimony before the US Copyright Royalty Judges, the Canadian Copyright Royalty Board, and the Federal Communications Commission. Mr. Trautman’s testimony has covered industry and business strategies and trends; valuation in relation to programming and other media assets; and market analysis of media industries. His consulting assignments have focused on business strategies, competitive assessments, and market research, as well as the ways in which media technologies and consumer behavior intersect. Mr. Trautman is the author of Unleashing Connectivity and Entertainment in America: A Study of the Cable Industry’s Impact and Public Television’s Transition to a Digital Future, as well as other writings on television and digital broadcasting.

Ms. Comstock has extensive experience applying economic and financial analyses to litigation and other complex business situations. She has assisted clients in all phases of the litigation process, including fact and expert discovery, trial preparation, and settlement negotiations. Ms. Comstock’s case work has involved litigation related to the high-profile bankruptcies of several firms. She has provided consulting support and supported experts in cases related to the alleged manipulation of different benchmark rates, including evaluations of the effects of alleged manipulation on the value of different derivatives and securities. She has also provided consulting and expert support in matters involving alleged violations of Rule 10b-5 and Section 11, and on matters related to mortgage-backed securities. Ms. Comstock has supported experts in ERISA-related litigations, alleged breach of contract matters, and other business and valuation disputes.

Read Laura's profile

Mr. Yenikomshian specializes in technology, data analysis, and economic modeling, and has consulted on technical, economic, and strategic issues to companies in a variety of industries, including computer software and technology, cybersecurity, blockchain and cryptocurrency, pharmaceuticals, and medical insurance. He has extensive experience analyzing technical issues, such as those relating to software and internet technologies, and translating them to a lay audience. Mr. Yenikomshian has analyzed the flows of data from user devices to third-party service providers such as analytics and advertising companies. He testified on behalf of the US Department of Justice in its criminal indictment of Jitesh Thakkar, who allegedly designed and sold a software program that assisted a commodities trader who was engaged in spoofing. In this matter, Mr. Yenikomshian’s role was to determine whether the software program that Thakkar produced operated the way that the trader’s requirements document had specified. He provided a detailed demonstration of how the requirements for the order types were translated into a software program by walking the court through the actual lines of code that implemented the requirements. Mr. Yenikomshian has also conducted numerous other software code reviews in a range of matters. In addition, he has developed interactive software tools to help clients make strategic decisions. Mr. Yenikomshian is a member of the American Bar Association and serves as co-chair of its Biotechnology, Healthcare Technology, and Medical Devices Committee. Previously, he served as co-chair of its Big Data Committee and Data Science Working Group, as well as vice chair of its Artificial Intelligence and Robotics Committee. Prior to joining Analysis Group, Mr. Yenikomshian was a partner in a software development and staffing technology firm.

Ms. Cotton has extensive experience conducting complex quantitative and qualitative analyses of data in both mergers and litigation matters. She has supported experts from leading universities and managed case teams in a broad range of industries on matters related to antitrust, bankruptcy, class certification, intellectual property, securities, survey design, tax, and transfer pricing. Her recent case work has included assessing competitive effects in major antitrust matters and mergers; analyzing Federal Trade Commission (FTC), US Department of Justice (DOJ), and Canadian Competition Bureau (CCB) merger compliance, including assistance with Hart-Scott-Rodino (HSR) filings, second requests, divestiture analysis, advocacy, and merger trial testimony; managing the independent evaluation of large-scale transaction and customer datasets in major antitrust matters; examining damages issues in a data breach context; and determining arm’s-length pricing in a large US transfer pricing matter. Ms. Cotton also has substantial experience evaluating questions of commonality and typicality in the context of privacy, technology, data breach, pharmaceutical, medical device, and overcharge class actions.

Dr. Furchtgott-Roth is a former commissioner of the Federal Communications Commission (FCC). During his FCC tenure, Dr. Furchtgott-Roth delivered testimony before numerous Congressional committees. Since leaving the FCC, he has served as an expert in a number of high-profile matters, including Liberty Media v. IAC/InterActiveCorp. and the XM/Sirius Satellite Radio merger.

Dr. Furchtgott-Roth is a frequent speaker on telecommunications, regulation, and high technology. He has authored books on cable television, telecommunications, and international trade in computer software, and has published more than 40 scholarly and popular articles in such outlets as the Antitrust Bulletin, The Columbia Science and Technology Law Review, the Federal Communications Law Journal, The Wall Street Journal, Investor's Business Daily, and Forbes.

Prior to his appointment to the FCC, Dr. Furchtgott-Roth served as chief economist of the US House of Representatives Committee on Commerce, where he was one of the principal staff involved in drafting the Telecommunications Act of 1996.

Mr. Kinrich consults on cases involving financial and economic analysis, accounting, business valuation, statistics, and mathematical modeling. He has often testified on damages, valuation, and accounting issues in federal and state courts and other dispute resolution forums. Over his 40-year career, Mr. Kinrich has directed numerous large-scale analyses involving a broad range of litigation areas. A certified public accountant, he specializes in damage quantification and valuation in the areas of commercial litigation and intellectual property. He also has significant experience in many other areas of the law, including breach of contract, construction, fraud, antitrust, business interruption, marital dissolution, dealership disputes, and tax litigation. Mr. Kinrich has authored a number of publications on damages-related topics, and recently co-edited the book entitled Lost Profits Damages: Principles, Methods, and Applications. Before joining Analysis Group, he was with PricewaterhouseCoopers for 20 years.

Mr. Beauregard specializes in conducting sophisticated economic, financial, and statistical analyses. His consulting experience includes many litigation and arbitration proceedings, as well as internal and regulatory investigations. He has supported experts and assisted counsel in a variety of antitrust, securities, ERISA, commercial litigation, and intellectual property matters.

In antitrust cases, Mr. Beauregard’s experience includes allegations of price-fixing, predatory pricing, price discrimination, concerted refusals to deal, and monopolization and attempted monopolization. His securities experience includes matters related to allegations of breach of fiduciary duty, securities fraud, and excessive mutual fund fees. In his ERISA work, Mr. Beauregard has led teams analyzing ERISA violations through the inclusion of inappropriate investment options or charging excessive fees, among other matters. Throughout multiple commercial litigation matters, he has supported academic experts on topics related to fraud, breach of contract, and tortious interference. Additionally, Mr. Beauregard has conducted lost profits and reasonable royalty damages analyses in a number of intellectual property cases.

Professor Blouin is an expert on the role of taxation in firm decision making. Her research examines the effect of taxes on asset pricing, capital structure, corporate payout behavior, multinational firm behavior, and mergers and acquisitions. She has also examined the effects of investor tax-sensitivity on portfolio rebalancing, price pressure, and fund performance. Professor Blouin has provided expert analysis and testimony in tax shelter litigation on behalf of the US Department of Justice, and in pharmaceutical patent litigation regarding transfer pricing and the repatriation of earnings by multinational corporations and their affiliates. Professor Blouin’s research has been published in peer-reviewed journals that include the Journal of Accounting and Economics and National Tax Journal, and she is an editor of the Review of Accounting Studies and an associate editor of the Journal of Accounting Research. Her work has been cited in The Wall Street Journal, The New York Times, and the Financial Times, as well as on NPR. She is a recipient of the University of Pennsylvania’s Lindback Award for Distinguished Teaching and Wharton Teaching Excellence Award. Prior to her academic career, Professor Blouin was a tax manager with Arthur Andersen.

Professor Venkataraman specializes in market microstructure and financial market design; the evaluation of trading strategies; and the functioning of equity, fixed-income, and energy markets. He has served as an expert witness in litigation matters involving trading strategies and price manipulation, and has consulted to the Financial Industry Regulatory Authority, the US Commodity Futures Trading Commission, and the US Department of Justice, among other organizations. He serves on the US Securities and Exchange Commission’s (SEC’s) Fixed Income Market Structure Advisory Committee, which advises the SEC on the efficiency and resiliency of fixed-income markets. Professor Venkataraman is an associate editor of the Journal of Financial and Quantitative Analysis and the Journal of Financial Markets. His research has been published in academic journals and featured in media outlets such as The Wall Street Journal, Barrons, the Financial Times, The Economist, and Bloomberg News, and has won best paper awards at international conferences. Professor Venkataraman teaches courses in investments and energy finance, and serves as the academic director of the Maguire Energy Institute. He has served as chairman of the Cox School of Business’s finance department. Professor Venkataraman is the recipient of multiple SMU awards, including the Altshuler Distinguished Teaching Professor Award and the Gerald J. Ford Senior Research Fellowship, and was named among “The Best 40 B-School Profs Under the Age of 40” by Poets&Quants.

Professor Tucker is an industrial organization economist whose research spans the fields of technology, health care, real estate, and media and advertising. A particular focus of her work is on the role of data and digitization on competition and consumer behavior. Professor Tucker has deep experience as an expert witness in a variety of cases spanning antitrust and competition, intellectual property, data and data privacy, online advertising, and digital platforms. She has assessed market definition, competitive effects, liability, and class certification issues in matters involving pharmaceuticals, health insurance, consumer goods, sports and entertainment, energy, and consumer electronics, among other industries. She has testified about the effects of data, privacy, and algorithms before Congress, and has presented her work to agencies and organizations such as the Federal Trade Commission (FTC), the Federal Communications Commission (FCC), the International Monetary Fund (IMF), the European Commission Directorate-General for Competition (DG COMP), and the Australian Competition and Consumer Commission (ACCC).

Professor Tucker has published widely on innovation and technology diffusion; online advertising, customer heterogeneity, and algorithms; privacy regulation; network effects; and the economics of social networks. At the National Bureau of Economic Research (NBER), she serves as a research associate, focusing on privacy; a principal investigator on the Project on the Economics of Digitization; and a co-organizer of the Economics of Artificial Intelligence initiative, supported by the Alfred P. Sloan Foundation. Professor Tucker is a co-founder of the MIT Cryptoeconomics Lab, which studies digital currencies and blockchain, and chair of the MIT Sloan Ph.D. Program. Her articles have appeared in leading scientific, economic, management, and marketing journals. She has previously served as associate editor of Management Science and the Journal of Marketing Research and coeditor of Quantitative Marketing and Economics, and she is currently senior editor of Marketing Science.

Dr. Befurt is an expert in applying marketing research methods to litigation matters and strategic business problems. He specializes in developing survey experiments and choice modeling approaches in consumer surveys. He has served as an expert witness in survey and sampling matters, and has assisted academic affiliates in survey conceptualization, administration, and evaluation. Dr. Befurt’s many clients include the US Department of Justice (DOJ), the US Federal Trade Commission (FTC), the Office of the Attorney General of New York, Microsoft, Oracle, Keurig Dr Pepper, Fiat Chrysler Automobiles, Ford, General Motors, Toyota, the Louisiana Farm Bureau, Cree Lighting, Research In Motion, and Nestlé. He has testified at numerous depositions and trials.

As an expert witness, Dr. Befurt has worked on matters pertaining to patent infringement, trademark disputes, consumer disclosures, product liability, false advertising, brand reputation, and sampling. He has extensive experience developing experimental studies and usage surveys, as well as modeling consumer choice, including conducting and examining conjoint analyses. Dr. Befurt’s work also includes the evaluation and application of market research techniques in the finance and automotive manufacturing sectors. He has designed survey instruments, analyzed complex survey data, and created tools to allow clients to understand consumer preferences and market forces through market simulations. Dr. Befurt’s experience spans over two decades and includes numerous projects for automobile manufacturers in Europe and the US. 

Professor Garrison is an academic expert with extensive experience in nonprofit health policy and pharmaceutical industry economics research. His research interests include US and international health policy issues related to personalized medicine; benefit-risk analysis; and the economic evaluation of pharmaceuticals, diagnostics, and other technologies. Professor Garrison is a visiting senior fellow at the Office of Health Economics (OHE) in London, and his research has been published more than 190 times in peer-reviewed journals. In 2022, he received the Avedis Donabedian Outcomes Research Lifetime Achievement Award from the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). He is co-chair of the Policy Outlook Committee for ISPOR’s Health Science Policy Council, and has served as a former president of IPSOR as well as chair or co-chair of ISPOR task forces on real-world data, performance-based risk-sharing arrangements, and US value frameworks. Prior to his academic career, he was vice president and head of Health Economics & Strategic Pricing for Roche Pharmaceuticals in Basel, Switzerland, and previously served as director of Project HOPE, a nonprofit corporation conducting health sciences education and training programs in 18 countries.

Professor Bosley is an economist specializing in microeconomics and behavioral economics, with a particular focus on examining the dynamics of multi-level marketing organizations (MLMs) in the US and worldwide, including the social and economic factors that influence participation in MLMs. She has been retained as an expert witness and testified at preliminary injunction hearings and trials in this area, and is frequently called upon to evaluate whether at-issue MLMs have misrepresented earning potential and whether they should be classified as pyramid schemes. Professor Bosley’s expert work has spanned numerous federal and state litigations, including before the Federal Trade Commission (FTC), the Securities and Exchange Commission (SEC), and the Washington State Office of the Attorney General. A frequent presenter at academic and industry conferences, she has also been featured in USA Today, as well as on the BBC, HBO, and NPR. Professor Bosley’s work has been published in numerous peer-reviewed journals, such as the Journal of Behavioral and Experimental Economics, The Journal of Consumer Affairs, and the Journal of Labor and Society. She teaches courses in microeconomic theory, behavioral economics, and econometrics, and has received multiple awards for her academic service and teaching. Prior to her career in academia, Professor Bosley was a consultant at Accenture.

Dr. Kirson is an applied health economist with extensive experience in health economics and outcomes research (HEOR), strategy and market access, and complex litigation matters. He specializes in the application of advanced statistical methods to the analysis of a variety of real-world and clinical data, as well as the development of advanced modeling tools. He has worked closely with many different stakeholders in the health care industry, including biopharmaceutical and device manufacturers, payers, government agencies, leading law firms, and academic experts. Dr. Kirson has managed numerous HEOR and strategy projects, including novel cost-effectiveness analyses, submissions to health technology assessment (HTA) organizations, the design of outcomes-based contracts, the analysis of pharmaceutical pricing, burden-of-illness studies, comparative-effectiveness research, and budget impact assessments. In the regulatory context, he has supported a successful 510(k) pre-market submission to the US Food and Drug Administration (FDA) on behalf of a medical device manufacturer, including the presentation of statistical analyses to an FDA advisory panel. In litigation, Dr. Kirson’s case work has included the evaluation of antitrust matters in the health care sector and the assessment of issues pertaining to the False Claims Act. His work has resulted in numerous conference presentations and peer-reviewed publications in leading journals such as Nature Reviews Drug Discovery, Health Affairs, Alzheimer’s & Dementia, and Diabetes Care, as well as various pharmacoeconomic journals. He has also published in non-academic outlets such as Health Affairs Forefront, STAT, and Law360. Dr. Kirson served on the board of the ISPOR Boston Regional Chapter, including a term as the Chapter President. He is also a member of the editorial board of the journal Pharmacoeconomics Open.

Professor Mitzenmacher’s research interests include the design and analysis of algorithms, networks and data transmission, computer security, information theory, and the use of encryption. He has consulted to technology companies and research laboratories such as Adverplex (Cogo Labs), Akamai, AT&T, Digital Fountain, eharmony, Fluent Mobile (Fiksu), Google, Huawei, ITA Software, JobSync, Microsoft, Mitsubishi Electric Research Laboratories, and Yahoo!. He has also served as an expert witness on software and intellectual property issues in several cases, and provided testimony in multiple trials. Professor Mitzenmacher has authored or coauthored over 200 conference and journal publications on a variety of topics, including algorithms for the internet, efficient hash-based data structures, erasure and error-correcting codes, power laws, and compression. He is also the coauthor of Probability and Computing, a textbook on randomized algorithms and probabilistic techniques in computer science. His work on low-density parity-check codes shared the 2002 IEEE Information Theory Society Best Paper Award and won the 2009 ACM SIGCOMM Test of Time Award. Prior to joining the Harvard faculty, Professor Mitzenmacher was a research scientist at Digital Equipment Corporation’s Systems Research Center, where he worked on information retrieval on the web, erasure and error-correcting codes, online algorithms, and load balancing.

Dr. Dawson specializes in applying economics and finance to complex problems in business litigation, including intellectual property (IP), false advertising, securities, and finance matters. Her experience spans several industries, from medical devices and high tech to telecommunications and accounting. Dr. Dawson has consulted to counsel in all phases of the litigation process, including understanding complex claims, assisting with fact and expert discovery, and providing trial support. She has served as an expert witness on matters involving false advertising, breach of contract, and copyright infringement. Dr. Dawson’s case work has involved complex data analysis, development of financial models, general damages assessment, evaluation of lost profits, royalty, and other damages remedies in IP and false advertising matters, ascertainment of loss causation and damages in securities fraud matters, and financial statement analyses. She has spoken at various conferences and served as a panelist on the topics of platform economics and IP damages.

Read Na's profile

Professor Ware is an internationally recognized leader in measuring Patient Reported Outcomes (PRO). His substantial contributions to the outcomes research field have focused on developing, standardizing, and applying health metrics to assess patient reported outcomes. His work has led to the development of a set of standardized, generic PRO measures, including the SF-36® Health Survey, as well as disease-specific measures such as the Headache Impact Test (HIT-6^TM) survey. Professor Ware frequently provides guidance on evidence support for PRO labeling, and he has been the invited expert for testimony on PRO topics at hearings held by the US Food and Drug Administration. His current research interests also include applying modern psychometric methods to construct more actionable measures, including the first disease-specific quality-of-life (QOL) impact scale standardized across conditions and normed in representative chronically-ill populations. Professor Ware is as a member of the National Academy of Medicine (formerly Institute of Medicine).

Professor Tufano’s work spans a broad range of topics in finance, including climate finance and derivatives and structured finance. His research interests include financial innovation, business solutions to climate change, the design of new securities and financial instruments, the organization of financial markets, corporate risk management, the mutual fund industry, and household finance. Professor Tufano has provided expert testimony and reports in several finance- and securities-related matters, including a matter involving retained asset accounts; the Parmalat securities litigation; economic characterizations of securities for tax courts; and the Enron Corporation securities, derivative, and ERISA litigations.

He has written a number of books, and his articles have been published in journals such as The Journal of Finance, the Journal of Financial Economics, The Review of Financial Studies, and Harvard Business Review. He is an associate editor of the Journal of Investment Management. Professor Tufano’s work has also been featured in a number of media outlets, including The New York Times and the Financial Times. He has received several awards, including the Smith Breeden Prize for the best finance paper published in The Journal of Finance and a leadership award from the Aspen Institute. Prior to re-joining the Harvard Business School faculty, he was dean of the Saïd Business School at the University of Oxford for a decade.

Dr. Betts specializes in the application of advanced biostatistics techniques in the field of health economics and outcomes research (HEOR). He has broad experience developing research strategies in a range of disease areas, including endocrinology, immunology, hematology, neurology, oncology, psychiatry, virology, and women’s health. Dr. Betts has developed and applied new research methods in the fields of individualized medicine methodology, meta-analyses/indirect comparisons, causal inference, Bayesian statistics, missing data problems, and risk prediction. His expertise includes the design and analysis of clinical trials, health economics modeling, indirect comparisons/network meta-analysis, causal inference, psychometrics, survey design, and retrospective database analyses (including administrative claims, electronic medical records, and registry data). Dr. Betts’s work includes developing risk-benefit analyses, cost-effectiveness models, and network meta-analyses for regulatory submission as well as treatment pattern and burden-of-illness research to support the launch of emerging products. His research has been published in peer-reviewed statistical, medical, and health economics journals and presented at clinical and economic research conferences.

Dr. Brackley is board certified in internal medicine and an expert in patient and medical safety. Her deep knowledge of clinical trial management includes clinical events committees and safety event reviews, as well as pharmacovigilance, post-market processes, field actions, and risk management. She has consulted on these issues to medical device, diagnostic, and pharmaceutical companies for over a decade. Dr. Brackley’s expert experience includes providing medical insight, post-market surveillance, and pharmacovigilance expertise in complex legal matters, in which she has submitted expert reports and testified at deposition; supporting legal teams in their review and understanding of complex medical and epidemiological issues; and reviewing medical records, complaints, and regulatory submissions. She has provided safety oversight and medical review expertise in clinical studies, and developed processes for clinical trial adjudication and data safety monitoring boards. In addition, Dr. Brackley has created strategies for developing and optimizing medical safety groups in the medical device, diagnostic, and pharmaceutical industries, including processes, procedures, organizational structure, implementation, and rollout. Earlier in her career, as a vice president and medical safety officer at Boston Scientific, she provided safety oversight and safety vigilance throughout the product life cycle and was involved in strategic decision making across all products worldwide. Prior to her roles in industry, Dr. Brackley completed a residency in internal medicine. She is a member of the American Medical Association, the Massachusetts Medical Society, and the Regulatory Affairs Professionals Society.

Professor Garthwaite is an applied microeconomist who studies the effects of government policies and social phenomena, particularly in the areas of health and biopharmaceuticals. His recent work focuses on the private sector effects of the Affordable Care Act, including the labor supply effects of large insurance expansions, the changes in uncompensated hospital care resulting from public insurance expansions, and the responses of nonprofit hospitals to financial shocks. Professor Garthwaite also studies biopharmaceutical pricing and innovation, including the effect of expanded patent protection on pricing in the Indian pharmaceutical market, the effects of increases in demand on innovation by US pharmaceutical firms, and the relationship between health insurance expansions and high drug prices. Additionally, he studies the effects of the increased use of private firms to operate and manage social insurance programs, with a focus on Medicaid managed-care firms. 

Professor Garthwaite has testified before the US House of Representatives and several state legislatures on the minimum wage, health care reforms, and consolidation in health care markets. He has also held several public policy positions, including faculty associate with Northwestern University's Institute for Policy Research and director of research for the Employment Policies Institute. Professor Garthwaite's research has appeared in journals such as The Quarterly Journal of Economics, American Economic Review, The Review of Economics and Statistics,  and Health Affairs;  and has been profiled in media outlets such as The New York Times, The Wall Street Journal, The Washington Post,  and Vox. He has also appeared on various TV and radio programs, including Nightly Business Report and Marketplace.

Mr. Korman is an expert on issues related to finance, regulatory, antitrust, and class action matters, with extensive experience in securities litigation. His experience includes performing damages exposure analyses, supporting counsel in mediation, and supporting experts in their preparation of testimony and reports on class certification, liability, and damages issues in numerous Rule 10b-5 and Section 11 matters, including the securities fraud class action matter T. Jeffrey Simpson, et al. v. Homestore.com, Inc., et al. – one of the relatively few securities fraud matters that has proceeded to trial – and recent securities matters in the high-tech, health care, energy, and industrial sectors, among others. In the context of ERISA litigation, he has evaluated investment performance, fees, portfolio management, mutual funds, and stable value funds.

Mr. Korman has extensive experience analyzing market power in wholesale electric power markets. He has analyzed such markets in several M&A proceedings, and supported the preparation of numerous wholesale power market analyses related to company applications for market-based rate authority from the Federal Energy Regulatory Commission (FERC). He has also provided testimony on these issues to FERC on several occasions.

In addition, Mr. Korman has published on topics related to the energy and financial markets, including contributing a chapter titled “Federal Securities Acts and Areas of Expert Analysis” to the Litigation Services Handbook.

Dr. Mordecai is an expert on forensic financial and economic analysis, financial engineering, and the valuation of fixed-income securities and structured products, including over-the-counter derivatives – in particular, fixed-income and credit derivatives. He also has expertise in complex insurance and reinsurance liabilities, M&A and successor liability analysis, operational risk, reliability and warranty-indemnity analysis, environmental liability, trade credit, and political risk, as well as asset liability and risk management models and practices. In addition, Dr. Mordecai has direct experience with cryptocurrency and digital asset technology infrastructure, including the technical review and evaluation activities of distributed ledger technology. Dr. Mordecai has advised on, and provided technical oversight for, pattern and practice investigations, internal regulatory investigations, insurance investigations for state regulators, and stress testing for global financial institutions. He has testified extensively at deposition, trial, arbitration, and international arbitration; been admitted as an expert in federal, state, and county courts; and been cited favorably in court decisions. Dr. Mordecai has served as an advisor on systemic risk issues to the Federal Reserve, the International Monetary Fund (IMF), the US Department of the Treasury, and the Commodity Futures Trading Commission (CFTC), and as an advisor on hedge fund valuation issues to the International Organization of Securities Commissions. He has also been a member of the Investment Advisory Committee of the New York Mercantile Exchange (NYMEX). In addition to his role at The University of Chicago Booth School of Business, Dr. Mordecai is a visiting scholar at the NYU Courant Institute of Mathematical Sciences, where he co-advises research activities at the RiskEcon® Lab for Decision Metrics. Dr. Mordecai also co-teaches a course at NYU Law School on quantitative methods in litigation with a focus on machine testimony and machine behavior. His contributions to this course as co-instructor include extensive direct experience with technical review, evaluation, and testing of AI and machine learning applications across diverse institutional contexts, as well as industry and market settings.

Ms. Comeaux specializes in the application of finance and economics to complex business litigation and damages estimation. She has led teams across a broad range of matters involving commercial disputes, antitrust and competition, and securities and finance. Her clients include leading media and technology companies, financial institutions, global manufacturers, and life sciences companies. Ms. Comeaux has provided assistance through all phases of pretrial and trial practice, including expert search, fact discovery, class certification, quantification and rebuttal of damages, expert testimony, trial preparation, and settlement negotiations. She has also assisted clients in mass arbitration proceedings, regulatory investigations, and strategy engagements.

Ms. Comeaux has experience with a wide range of empirical methodologies, particularly within the context of damages analyses. Her work regularly involves critical examination of theories of liability, development of models to quantify damages, and both quantitative and qualitative analyses in response to allegations of negligence or punitive damages. She has worked with a wide variety of academic and industry experts to assess organizational, industry, and market conditions in order to contextualize analyses of damages. Ms. Comeaux has particular expertise in organizational assessments that address theories of liability, including reviewing and responding to the results of assessments conducted by regulators and third parties.

Roger Ware is a professor of economics at Queen's University, Kingston, Canada. He has held previous positions at the University of Toronto and the University of California, Berkeley. From 1993 to 1994 he held the T.D. McDonald Chair in Industrial Organization at the Competition Bureau, Ottawa. Dr. Ware's interests are focused on industrial organization, antitrust economics, intellectual property, telecommunications, and energy economics. In addition to publishing many articles in these areas, Professor Ware coauthored (with Dr. Jeffrey Church) Industrial Organization: A Strategic Approach (McGraw-Hill, 2000), a major text on antitrust economics that is frequently cited by experts and practitioners.

Dr. Ware teaches graduate and undergraduate courses in industrial organization, regulation and law, and economics and has lectured widely on antitrust topics. He has consulted on many recent competition cases, and has appeared as an expert witness several times before Canada's Competition Tribunal and other regulatory tribunals and agencies. His expert testimony on behalf of the respondent in Commissioner of Competition v. Canada Pipe, Ltd. (2005) played a key role in a major decision of the Competition Tribunal, which in turn led to a landmark ruling from the Federal Court of Appeals. In recent years, Dr. Ware has also been retained as an expert in several important Canadian Class Certification cases and cases involving the regulation of telecommunications, Internet services, and broadcasting.

Arnold Barnett's research specialty is applied mathematical modeling generally focused on problems of health and safety. His early work on homicide was presented to President Ford at the White House, and his analysis of US casualties in Vietnam was, among other things, the subject of a column by William F. Buckley. He has received the President's Award and the Expository Writing Award from INFORMS (1996 and 2001, respectively) and the President's Citation from the Flight Safety Foundation (2002) for “truly outstanding contributions on behalf of safety.” He has written op-ed pieces for The New York Times, The Wall Street Journal, The Boston Globe, and USA Today. Ten times he has been honored for outstanding teaching by students at MIT's Sloan School of Management; in 1992, Business Week described him as the “best” Sloan School faculty member. Dr. Barnett has testified in many legal proceedings as a statistical expert and an aviation-safety expert.

Dr. Borek specializes in the application of microeconomics, finance, and statistics to litigation and complex business problems. He has managed economic analyses presented in numerous intellectual property, antitrust, consumer harm, finance, and tax disputes. Selected cases where the economic analysis played a central role include the following:

• Dr. Borek led an Analysis Group case team in support of economic, marketing, and accounting experts who provided damages testimony on behalf of Samsung Electronics in a patent dispute with Apple, Inc. After finding infringement, a San Jose, California jury ordered Samsung to pay $119.6 million in damages, far short of the $2.2 billion sought by Apple.
• Dr. Borek also led a case team in support of marketing experts who provided testimony on behalf of Samsung Electronics in an earlier patent dispute with Apple. Citing this testimony, a federal judge in California denied Apple's motion to obtain a permanent injunction against several smartphones and tablets marketed by Samsung Electronics, because Apple had failed to establish a causal nexus between Apple's patents and the demand for Samsung's products. The decision was upheld on appeal.
• Dr. Borek led a case team in support of economic, finance, and accounting experts who provided trial testimony in support of the US Department of Justice in a tax dispute with Wells Fargo. Citing the expert testimony extensively, a federal judge in Minnesota disallowed Wells Fargo's tax refund related to $423 million in claimed capital losses because the underlying corporate reorganization lacked business purpose and economic substance. The decision was upheld on appeal.
• Dr. Borek led a case team in support of a marketing expert who provided testimony on behalf of Google in a class certification proceeding involving users of Google's AdWords service. A federal judge in the Northern District of California denied the plaintiffs' motion for class certification. The decision, which referenced the expert testimony extensively, noted that "individualized issues of restitution permeated the class claims."
• Dr. Borek led a case team in support of finance, economic, accounting, and corporate governance experts retained on behalf the former CEO of a leading technology company accused of backdating employee stock options. The multiple associated investigations were resolved through a deferred prosecution agreement.
• Dr. Borek has led case teams in support of multiple marketing experts retained to provide testimony in support of successfully culminated mergers.

Dr. Borek also serves as a Senior Policy Scholar at the Center for Business and Public Policy in Georgetown's McDonough School of Business, and previously held positions with Ernst & Young's Corporate Finance practice and Chernivtsi State University in Ukraine, where he taught international trade and international finance. His research, presented in journals and before professional and academic audiences, has focused on innovation, industrial organization, international trade, labor economics, and corporate governance.

Professor Christoffersen’s research focuses on mutual funds, hedge funds, and the role of financial institutions in capital markets. She has been retained as an expert in litigation matters to address topics such as mutual fund market timing and trading strategy issues. She has published in a number of finance journals, and her work has been cited in The New York Times, the International Herald Tribune, Bloomberg News, and The Wall Street Journal. Professor Christoffersen has received grants from Canada’s Social Sciences and Humanities Research Council, the Montreal Financial Mathematics Institute, and the Quebec Research Funds, as well as research awards from Q Group, the Bank of Canada, the BSI Gamma Foundation, INQUIRE, and the Swiss Finance Institute. Prior to joining the faculty at the University of Toronto, she held positions at McGill University, Copenhagen Business School, and the Department of Finance Canada.

Professor Gentzkow specializes in applied microeconomics, empirical industrial organization, and political economy, with a focus on the media, technology, retail, and health care industries. He studies the economic forces driving the creation of media products; competition in media markets; the changing nature and role of media in the digital environment; and the effects of media on education, ideological diversity, and civic engagement. His work has examined the welfare effects of social media networks and how information is disseminated online. Professor Gentzkow’s research has also involved the analysis of complex datasets of consumer purchases to study consumer product pricing, consumer brand preferences, and brand price premiums. He has presented his work to the US Department of Justice, Federal Trade Commission, and Federal Communications Commission.

Professor Gentzkow has published in numerous prominent economic journals and has appeared frequently in major media such as The New York Times, The Wall Street Journal, The Economist, The Washington Post, and NPR. His awards include the John Bates Clark Medal, given by the American Economic Association to the American economist under 40 judged to have made the most significant contributions to economic thought and knowledge. He is a research associate at the National Bureau of Economic Research and a member of its Industrial Organization Program steering committee, and a senior fellow at the Stanford Institute for Economic Policy Research. Professor Gentzkow has received a fellowship and grants from the Alfred P. Sloan Foundation, as well as various grants from the National Science Foundation.

Mr. Laliberté specializes in biostatistics and the economics of health outcomes research. He investigates multiple facets of health research, including safety, cost of illness, resource utilization, adherence to therapies, cost effectiveness, and treatment outcomes. Mr. Laliberté’s varied research has examined numerous forms of mental illnesses, respiratory diseases, cancer, cardiovascular diseases, and rare diseases. His expertise includes the retrospective database analysis of claims and electronic medical records, as well as clinical trial data analyses. He has implemented innovative data solutions such as Komodo Health, Mass General Brigham’s Research Patient Data Registry, and IQVIA to address clients’ research questions. Mr. Laliberté’s research has been presented at conferences of the American Heart Association (AHA) and the American Society of Clinical Oncology (ASCO), among others. He has published over 100 papers in medical journals, including CHEST, the American Journal of Hematology, and the Journal of Affective Disorders.

Professor Ketcham is a health care economist with over two decades of experience researching, teaching, and consulting. His areas of expertise include pharmaceutical advertising and promotion, pharmacy benefit managers, health insurance, consumer decision making, physician decision making, hospital pricing, provider incentive programs and payment methods, fair market valuation, employee benefits, and valuation of changes in morbidity and mortality. From 2022 to 2024, Professor Ketcham took a leave from the W.P. Carey School of Business to serve as senior economic advisor to the employee benefits team of a major high-tech company. He has consulted for and collaborated with several large pharmaceutical firms, Banner Health, CVS Caremark, Symphony Health Solutions, the Centers for Medicare & Medicaid Services, the US Department of Health and Human Services, and the US Environmental Protection Agency. Professor Ketcham’s research has been published in journals such as the American Economic Review, The Review of Economic Studies, the American Journal of Health Economics, and Health Affairs. He has served as principal investigator on multiple grants, including federal government grants to study physician decision making, incentive programs, and provider pricing.

Dr. DerSarkissian’s expertise includes the application of epidemiologic methods to real-world evidence (RWE) generation in support of product registration, post-approval safety studies, and health economics and outcomes research (HEOR). She has served as an expert witness in litigation and has a wide range of experience in pharmacoepidemiology, biostatistics, and observational data analysis, including in studies on causal methods. Dr. DerSarkissian has provided regulatory and strategic consulting on drug and medical device registration and conducted RWE studies related to US Food and Drug Administration (FDA) and European Medicines Agency (EMA) submissions. She has conducted cost-effectiveness and comparative effectiveness studies; examined treatment patterns, drug adherence, health care resource utilization and costs, and clinical outcomes; assessed direct medical and indirect productivity costs of a disease burden; and assessed patient-reported quality of life and the humanistic burden of a disease. Dr. DerSarkissian has used data from electronic medical records, clinical trials, commercial insurance claims, patient surveys, and medical chart review studies in disease areas that include obesity; HIV/AIDS; cardiovascular diseases; schizophrenia; autoimmune, neurologic, and rare hereditary disorders; and many types of cancer. She has presented her research at conferences on epidemiology and health services, and published articles in a number of peer-reviewed journals. Dr. DerSarkissian is an adjunct assistant professor in the epidemiology department at the UCLA Fielding School of Public Health.

Read Maral's profile

Professor Weber is a deeply experienced technologist whose multidisciplinary research has focused on innovation in technology markets, intellectual property regimes, and the related behaviors of people, firms, and governments. His research, teaching, and advisory work centers on both private and public sector issues around information technology, software, cybersecurity, privacy, algorithms, and health care. Professor Weber has advised global technology companies, government agencies, and nonprofit organizations on strategy and risk analysis, using a diverse set of qualitative and quantitative methods fit to purpose. In litigation, Professor Weber has been retained on behalf of technology companies to analyze aspects of technological integration, including those involving data security and algorithms. He was the founder and faculty director for the UC Berkeley Center for Long-Term Cybersecurity, and his cybersecurity credentials enable him to supplement his experience in organizational governance issues with an understanding of the technical nature of security threats and responses. Professor Weber served as a special consultant to the president of the European Bank for Reconstruction and Development, and has held academic fellowships with the Council on Foreign Relations and the Center for Advanced Study in the Behavioral Sciences. He is a widely published author, whose books include The Success of Open Source and Bloc by Bloc: How to Build a Global Enterprise for the New Regional Order, which explains how economic geography is increasingly defined by technology rules and standards.  

Mr. Giles is a financial economist focusing on valuation and financial analysis. He has worked extensively in international arbitration, including commercial treaty claims, and has been engaged in some of the most complex and high-profile financial and non-financial disputes. His experience covers a range of industries across the world, including financial services, energy, pharmaceuticals, software, luxury goods, mining, manufacturing, property development, and hotels. Mr. Giles has testified as a quantum expert in all the major international arbitration forums and in a number of High Court of Justice cases in London. In Galapagos Bidco S.À.R.L. v. Dr. Frank Kebekus, et al., a contentious financial restructuring, he was instructed by counsel for Galapagos Bidco S.À.R.L. Mr. Giles has also assessed the impact of restated accounts on the value of Autonomy in HP/Autonomy v. Lynch and Hussain; other restructurings, including Saltri III Ltd v. MD Mezzanine SA SICAR; and the challenge to the $50 billion Yukos award in the Netherlands.

Professor Chevalier is an expert in industrial organization, finance, and competitive business strategy. She has provided expert testimony and been deposed in several major antitrust matters, including State of New York v. Intel Corporation, in which she assessed the business strategies of competitors in the semiconductor industry and evaluated market outcomes. An affiliate with Analysis Group, Professor Chevalier, supported by Analysis Group teams, recently served as an expert in litigation involving online search databases, and in several matters involving entertainment industry issues related to rights, prices, and competition. She has also assisted a number of major technology firms with analyses of competition and antitrust issues. Professor Chevalier's academic research focuses on the economics of electronic commerce, the interaction between firm capital structure and product market competition, and price seasonality and cyclicality. Her research has been featured in Slate magazine and on National Public Radio. Professor Chevalier is also an elected member of the American Academy of Arts and Sciences. She is a former member of the American Economic Association's (AEA) Executive Committee and a former board member of the organization's Committee on the Status of Women in the Economics Profession. In 1999, she won the first biennial Elaine Bennett prize, given by the AEA in recognition of research by a woman in any area of economics. Professor Chevalier is an active author. She has published articles in the American Economic Review; Journal of Industrial Economics; Journal of Business; Quarterly Journal of Economics; Journal of Finance; Journal of Law, Economics, and Organization; and Journal of Political Economy. She is a former coeditor of the Rand Journal of Economics and has served as a coeditor of the American Economic Review, editor of the B.E. Journal of Economic and Policy Analysis, advisory editor of Quantitative Marketing and Economics, and associate editor of numerous journals.

Mr. Lefebvre specializes in the application of biostatistics and economics of health outcomes research. He has conducted and directed numerous studies in pharmacoeconomics, epidemiology, and health outcomes research in a variety of therapeutic areas such as anemia, asthma, cardiovascular diseases, chronic obstructive pulmonary disease, diabetes, genetic syndrome, hematology, hypertension, infectious diseases, myelodysplastic syndromes, neurological disorders, obesity, oncology, renal diseases, respiratory diseases, and women’s health. His recent work in the health care sector includes numerous clinical trials and medical claims data analyses to investigate resource utilization patterns, patient-reported quality of life, clinical effectiveness, direct medical and indirect productivity costs of a disease burden, and cost-effectiveness associated with the use of pharmaceuticals.

His extensive research is reflected in over 100 peer-reviewed publications in prominent clinical and health economics journals, such as Neurology, Journal of Allergy and Clinical Immunology, Journal of the American Society of Nephrology, Cancer, Hypertension, American Journal of Managed Care, Journal of Managed Care Pharmacy, Value in Health, and PharmacoEconomics. His scientific research has also resulted in numerous presentations at health care conferences as well as presentations to the FDA and CMS, and has included several high-profile studies publicized in the media, including a recent article on the economic burden of vasomotor symptoms in post-menopausal women cited in The Wall Street Journal blog Pharmalot.

Mr. Lefebvre has also served as a peer reviewer for several journals, including CHEST, Annals of Oncology, Clinical Journal of the American Society of Nephrology, Allergy & Asthma Proceedings, Journal of Managed Care Pharmacy, American Journal of Managed Care, Value in Health, and PharmacoEconomics. He is also a member of the International Society of Pharmacoepidemiology and the International Society of Pharmacoeconomics and Outcomes Research. Prior to joining Analysis Group, Mr. Lefebvre was an economist with the Québec Ministry of Finance.

Read Patrick's profile

Professor Eden is an expert on transfer pricing and multinational enterprises (MNEs), with decades of experience consulting to MNEs, governments, and international organizations on transfer pricing and MNE strategies and structures. In transfer pricing matters, she has served as an expert witness – in cases that include Coca-Cola Co. v. Commissioner and In re: Nortel Networks – and filed numerous expert reports. Professor Eden has taught courses on transfer pricing, MNEs, and the economics of international business, and founded the Transfer Pricing Aggies program at Texas A&M University, which has trained hundreds of graduate students. She has extensive research experience in areas such as transfer pricing and MNE strategies in the digital economy, and citations to her publications place her in the top 2% of research scientists worldwide. Professor Eden has authored several books, including Taxing Multinationals: Transfer Pricing and Corporate Income Taxation in North America, Multinationals in North America, The Economics of Transfer Pricing, and Research Methods in International Business. She is a frequent speaker at transfer pricing and tax conferences, as well as a former president and dean of the Fellows of the Academy of International Business. She is a currently a member of the United Nations Tax Committee’s Subcommittee on Transfer Pricing.

Dr. Chapsal is an economist who specializes in empirical and theoretical industrial organization. He has provided economic expertise in a large number of high-profile cases involving mergers, cartels, information exchanges, abuses of dominant positions, regulation, intellectual property matters, and damages quantifications. Recent examples include the Lafarge/Holcim and Fnac/Darty mergers, as well as airfreight, cathode ray tube, and elevator cartel cases. Dr. Chapsal has also assisted various firms in designing optimized pricing strategies and dealing with policy issues. His reports have been presented to the competition authorities of France, Germany, Austria, and South Africa; the European Commission; the Higher Regional Court of Düsseldorf; and the Court of Appeals, Conseil d’Etat, Conseil constitutionnel, and Tribunal of Commerce of Paris.

Prior to joining Analysis Group, Dr. Chapsal founded MAPP, a Paris- and Brussels-based economic consultancy, which was acquired by KPMG in 2018. Previously, he worked in a US competition economics consultancy. Dr. Chapsal regularly publishes articles on competition economics, on subjects ranging from the econometric analysis of cartels to geographic market delineation and exclusionary strategies. He is an affiliated professor at the Sciences Po Department of Economics and a member of the CESifo academic research network.

Professor Wei is the scientific director for the program of quantitative science in pharmaceutical medicine at the Harvard T.H. Chan School of Public Health. He is an expert in biostatistics and in the development of statistical methods for the design and analysis of clinical trials, and has provided deposition and trial testimony in numerous matters regarding the effectiveness of various therapies. Professor Wei also has served as an expert and advisor to a number of pharmaceutical companies and regulatory agencies, including the US Food and Drug Administration (FDA), and has served on a number of FDA and National Institutes of Health committees.

Professor Wei has developed numerous statistical methods that are utilized extensively in practice. He has concentrated his recent research on the development of personalized medicine strategies for diagnostics and treatment selection, and has been intimately involved in advising the pharmaceutical industry on new drug applications.

The author of more than 140 articles in statistical and medical journals, Professor Wei has served on the editorial boards of the Journal of the American Statistical Association and the Journal of Biopharmaceutical Statistics. He is an elected fellow of the Institute of Mathematical Statistics and the American Statistical Association, which honored him with the Mosteller Statistician of the Year award in 2007. 

Dr. Duh, Chief Epidemiologist at Analysis Group, specializes in real-world evidence (RWE) generation for product registration, post-approval safety studies, and health economics and outcomes research (HEOR) of pharmaceuticals, vaccines, and regenerative biotherapeutics. She has led multiple projects for new molecular entity approvals and product label expansion applications to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA), as well as health technology assessment (HTA) research for submissions to national payers such as the Centers for Medicare and Medicaid Services (CMS) in the US and the UK’s National Institute for Health and Care Excellence (NICE). Her extensive research has appeared in over 315 peer-reviewed publications.

Her work also extends to pharmaceutical liability litigation and securities fraud litigation related to adverse drug events that allegedly led to product recalls, market withdrawals, black box warnings, and FDA limited access programs.

Dr. Duh is also an adjunct in the biostatistics department at the Harvard T.H. Chan School of Public Health. She served as a chairperson of drug safety and epidemiology for the Drug Information Association (DIA) and was an adjunct assistant professor of pharmacoeconomics and pharmacoepidemiology at Massachusetts College of Pharmacy and Allied Health Sciences. Dr. Duh was appointed to an expert panel convened by the Foundation for the National Institutes of Health’s (FNIH’s) Observational Medical Outcomes Partnership (OMOP). She has served as a peer reviewer for several journals, including PharmacoEconomics, the American Journal of Health-System Pharmacy, Chest, Pharmacoepidemiology and Drug Safety, the American Journal of Kidney Diseases, and Therapeutics and Clinical Risk Management. Dr. Duh is also an elected member of the American Society of Hematology and a member of the American Society of Clinical Oncology, the International Society of Pharmacoepidemiology, and the International Society of Pharmacoeconomics and Outcomes Research (ISPOR).

View Dr. Duh's selected publications on the Harvard Catalyst website